- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03133663
Heart Rate Evaluation and Resuscitation Trial in Preterm Neonates (HEART)
December 19, 2018 updated by: Vishal Kapadia, University of Texas Southwestern Medical Center
The purpose of this study is to determine whether using electrocardiograms (ECGs) during resuscitation of preterm infants (less than 31 weeks gestation) will decrease the amount of time it takes from birth for heart rate (HR) to be above 100 beats per minute and oxygen saturations to be in the goal range, in other words to stabilize the infant.
A few studies have been conducted which showed that ECGs are faster at detecting HR than pulse oximetry (PO).
Sample sizes, however, have been small and only few extremely low birthweight infants have been included.
It is unclear if use of ECG in these tiny preterm infants in addition to traditional techniques to determine HR will be beneficial and impact resuscitation and outcomes.
The investigators propose a study where infants will be randomized to either using ECG in addition to PO ± auscultation versus PO ± auscultation only to assess HR during neonatal resuscitation.
The investigators hypothesize that the group of infants randomized to ECG will be able to stabilize faster, i.e. achieve HR > 100 beats per minute and oxygen saturation in goal range faster.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75235
- Parkland Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 hour (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Preterm infants less than <31 weeks gestation born at Parkland hospital vaginally or by C/S
- Infant with congenital heart disease, congenital anomalies, or chromosomal abnormalities will be included unless comfort care has been agreed upon beforehand
- Resuscitation team present to attend delivery before birth
Exclusion Criteria:
- Any infant with prenatally agreed upon comfort care since resuscitation will not be provided
- Any precipitous delivery since resuscitation team will not be in attendance prior to delivery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
Pulse oximeter and auscultation to determine heart rate during neonatal resuscitation.
Pulse oximeter will be used to determine oxygen saturation.
|
Control
|
Experimental: Electrocardiogram group
Electrocardiogram to determine heart rate during neonatal resuscitation.
Pulse oximeter will still be used per Neonatal Resuscitation Program guidelines for oxygen saturation.
|
Experimental
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to Infant Stabilization
Time Frame: During delivery room resuscitation, up to 1 hour
|
Amount of time it takes from birth for heart rate to be above 100 beats per minute and oxygen saturation to be in the goal range (per Neonatal Resuscitation Program guidelines)
|
During delivery room resuscitation, up to 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to heart rate >100 beats per minute
Time Frame: During delivery room resuscitation, up to 1 hour
|
Time in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Time to goal oxygen saturation
Time Frame: During delivery room resuscitation, up to 1 hour
|
Time in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Time of positive pressure ventilation
Time Frame: During delivery room resuscitation, up to 1 hour
|
Total time positive pressure received in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Incidence of positive pressure ventilation
Time Frame: During delivery room resuscitation, up to 1 hour
|
Positive pressure ventilation applied in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Incidence of CPR
Time Frame: During delivery room resuscitation, up to 1 hour
|
CRP applied in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Incidence of intubation
Time Frame: During delivery room resuscitation, up to 1 hour
|
Intubation in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Maximum FiO2 applied
Time Frame: During delivery room resuscitation, up to 1 hour
|
FiO2 applied in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Maximum peak inspiratory pressure
Time Frame: During delivery room resuscitation, up to 1 hour
|
Maximum peak inspiratory pressure in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Incidence of hypothermia
Time Frame: Until hospital discharge, up to 6 months
|
Hypothermia on admission to NICU
|
Until hospital discharge, up to 6 months
|
Incidence of need for surfactant
Time Frame: Until hospital discharge, up to 6 months
|
Surfactant given while in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of bronchopulmonary dysplasia
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of respiratory distress syndrome
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of pneumothorax
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of intraventricular hemorrhage
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of necrotizing enterocolitis
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of sepsis
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of symptomatic PDA
Time Frame: Until hospital discharge, up to 6 months
|
Incidence in NICU
|
Until hospital discharge, up to 6 months
|
Incidence of appropriate vs inappropriate use of positive pressure ventilation
Time Frame: During delivery room resuscitation, up to 1 hour
|
Use in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Incidence of equipment failure of pulse oximeter and electrocardiogram
Time Frame: During delivery room resuscitation, up to 1 hour
|
Failure in delivery room
|
During delivery room resuscitation, up to 1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 13, 2017
Primary Completion (Actual)
March 23, 2018
Study Completion (Actual)
March 23, 2018
Study Registration Dates
First Submitted
April 22, 2017
First Submitted That Met QC Criteria
April 25, 2017
First Posted (Actual)
April 28, 2017
Study Record Updates
Last Update Posted (Actual)
December 21, 2018
Last Update Submitted That Met QC Criteria
December 19, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 092016-048
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Resuscitation
-
University Hospital PadovaDoctors with Africa - CUAMMCompletedNeonatal ResuscitationEthiopia
-
Columbia UniversityCompletedNeonatal ResuscitationUnited States
-
University of PadovaUnknownNeonatal ResuscitationVietnam
-
St. Justine's HospitalUnknownSimulation | Neonatal Resuscitation
-
IlumensCompleted
-
The University of Texas Health Science Center,...Completed
-
University Hospital PadovaCompletedNeonatal Resuscitation | Heart Rate AssessmentItaly
-
Ahmed MoussaRecruiting
-
University of LahoreCompletedNursing Students Education on Neonatal ResuscitationPakistan
Clinical Trials on Pulse oximeter and auscultation group
-
William Beaumont HospitalsCompletedAsthma in Children | Respiratory Disease | Bronchiolitis Acute | Pneumonia in ChildrenUnited States
-
Nihon KohdenUniversity of California, San FranciscoCompleted
-
Nihon KohdenUniversity of California, San FranciscoActive, not recruiting
-
The Lifebox FoundationJohns Hopkins University; University College, London; Bill and Melinda Gates... and other collaboratorsCompletedPneumonia in Children | Measurement of Peripheral Oxygen SaturationUnited Kingdom, Bangladesh, Malawi
-
Belun Technology Company LimitedClinimark, LLCCompleted
-
Rigshospitalet, DenmarkThe Novo Nordic Foundation; Laegeforeningens ForskningsfondRecruitingHypoxia | Trauma | Trauma Injury | Oxygen Deficiency | HypoxemiaDenmark
-
Nihon KohdenUniversity of California, San FranciscoRecruiting
-
Nihon KohdenUniversity of California, San FranciscoRecruiting
-
Movano HealthUniversity of California, San FranciscoCompleted
-
Nihon KohdenUniversity of California, San FranciscoCompleted